Skip to main content
EMVISION MEDICAL DEVICES LTD logo

EMVISION MEDICAL DEVICES LTD — Investor Relations & Filings

Ticker · EMV ISIN · AU0000028375 ASX Manufacturing
Filings indexed 304 across all filing types
Latest filing 2020-10-26 AGM Information
Country AU Australia
Listing ASX EMV

About EMVISION MEDICAL DEVICES LTD

https://emvision.com.au/

EMVision Medical Devices Ltd is a medical technology company focused on the development and commercialization of portable medical imaging devices. The company specializes in electromagnetic microwave imaging technology designed for the rapid diagnosis and monitoring of stroke and traumatic brain injury. Its primary product is a portable brain scanner intended for use at the point of care, including intensive care units, emergency departments, and ambulances. By utilizing non-ionizing radiation, the technology provides a safe, cost-effective, and mobile alternative to traditional neuroimaging modalities like CT and MRI. The device aims to facilitate earlier clinical intervention by enabling bedside assessment, potentially improving patient outcomes through faster detection of ischemic and hemorrhagic strokes.

Recent filings

Filing Released Lang Actions
Notice of Annual General Meeting/Proxy Form 38 pages 742.3KB
AGM Information Classification · 100% confidence The document is titled 'NOTICE OF ANNUAL GENERAL MEETING' and contains detailed information about the upcoming AGM of EMVision Medical Devices Ltd, including the date, time, location, voting procedures, proxy forms, and resolutions to be considered at the meeting. It includes an agenda with resolutions such as adoption of the remuneration report, re-election of directors, and grant of options. The document is clearly a notice and explanatory statement related to the AGM, not the actual annual report or financial statements. It is a communication to shareholders about the meeting and how to participate, which fits the definition of AGM Information (AGM-R). The document length is substantial (15,000 characters), but it is not the report itself; it is the notice and related materials for the AGM.
2020-10-26 English
Appendix 3G - Issue of Options 16 pages 458.5KB
Share Issue/Capital Change Classification · 100% confidence The document is an Appendix 3G form filed by EMVision Medical Devices Ltd, notifying the issue of employee options (750,000 unlisted options) under an employee incentive scheme. It is a regulatory announcement about the issuance of new equity securities (employee options) and includes detailed information about the securities issued, their terms, and compliance with ASX rules. The document is not a financial report, earnings release, or management discussion. It is a formal notification of a capital change related to share options issued to employees. Therefore, the appropriate classification is 'Share Issue/Capital Change' (SHA). The document length and content confirm it is a full announcement, not just a brief notice or report publication announcement.
2020-10-22 English
Date of AGM & Closing Date for Director Nominations 2 pages 144.6KB
AGM Information Classification · 95% confidence The document is a short announcement (4614 characters) from EMVision Medical Devices Limited regarding the date of their 2020 Annual General Meeting (AGM) and the closing date for director nominations. It references the AGM date and states that further details will be provided in a separate Notice of Meeting. There are no financial statements, detailed presentations, or voting results included. The document serves as an informational notice about the AGM scheduling and director nomination deadline, not the AGM materials themselves or any detailed report. Therefore, it fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the AGM or related announcements about the AGM itself. The document is not a report publication announcement or regulatory filing since it provides substantive AGM-related information. Confidence is high due to clear references to AGM date and director nominations, typical of AGM Information filings.
2020-10-07 English
Change of Director's Interest Notice 3 pages 182.5KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details a director's change in relevant interests in securities, including the number of shares held before and after the change, the nature of the interest, and the value of the transaction. This is a clear report of personal share transactions by a company director. The document length is 3985 characters, which is consistent with a detailed notice rather than a brief announcement. The content matches the definition of Director's Dealing filings, which report insider trades by directors and executives. Therefore, the correct classification is DIRS (Director's Dealing).
2020-10-01 English
Dr Philip Dubois Appointed as Non-Executive Director 3 pages 178.7KB
Board/Management Information Classification · 95% confidence The document announces the appointment of Dr. Philip Dubois as a Non-Executive Director of EMVision Medical Devices Ltd. It details his background, the terms of his engagement, and the resignation of a previous director. There is no financial data, earnings information, or report content. The document is clearly an announcement of a change in the company's board of directors, which fits the category of Board/Management Information (MANG). The document length is 7170 characters, which is sufficient for a detailed announcement but does not contain financial statements or report data. Therefore, the correct classification is MANG with high confidence.
2020-09-28 English
Initial Director's Interest Notice 2 pages 175.9KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3X Initial Director’s Interest Notice' and references ASX listing rule 3.19A.1 and section 205G of the Corporations Act. It details the director's relevant interests in securities, including shares held directly or indirectly, and interests in contracts. The content is focused on disclosure of personal shareholdings and interests of a company director. This matches the definition of 'Director's Dealing' filings, which report personal share transactions or holdings by company directors and executives. The document length is short and specific to director interests, not a broader financial or management report.
2020-09-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.